← Leaderboards
David J Mooney
Harvard University
$45,709,587
Attributed
$92,569,488
Total exposure
22
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$98,961,916 · 22
FDA$1,800,000 · 1
By mechanism
U24$42,950,374 · 2
R01$36,804,067 · 12
U54$10,140,206 · 2
R37$3,788,556 · 1
U01$2,909,935 · 1
DP3$2,432,818 · 1
Top collaborators
- William V Giannobile8 shared
- David H. Kohn8 shared
- Charles Sfeir8 shared
- William R Wagner8 shared
- David T Scadden7 shared
- David A Weitz7 shared
- Frank S Hodi6 shared
- Toshihisa Kawai5 shared
Most similar at Harvard University
Same institution · by research overlap
- David A Weitz$6,736,844
- Robert M Westervelt$767,479
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTissuesBiocompatible MaterialsSuccessTissue EngineeringIn VivoHydrogelsNovel StrategiesBaseNatural RegenerationAlginatesMalignant NeoplasmsCraniofacialTransplantationLeadResponsePolymersDesignCell AdhesionCuesSitePhenotypeIn VitroEngineering
Grant awards (111)
Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration$734,549
R01 · FY2025 · DK
Viscoelasticity and T Cell Production$581,904
R01 · FY2025 · CA · contact PI
Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation$6,151,035
U24 · FY2024 · DE
Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration$774,435
R01 · FY2024 · DK
Viscoelasticity and T Cell Production$585,468
R01 · FY2024 · CA · contact PI
Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation$6,282,265
U24 · FY2023 · DE
Viscoelasticity and T Cell Production$568,911
R01 · FY2023 · CA · contact PI
Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation$6,223,509
U24 · FY2022 · DE
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$536,311
R01 · FY2022 · DE · contact PI
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ$417,345
R01 · FY2022 · CA · contact PI
Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation$6,281,076
U24 · FY2021 · DE
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$549,756
R01 · FY2021 · DE · contact PI
3D Models of Immunotherapy$509,042
U01 · FY2021 · CA · contact PI
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ$425,863
R01 · FY2021 · CA · contact PI
Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation$6,314,301
U24 · FY2020 · DE
Mechanisms of Prosthetic Arterial Bypass Graft Failure$756,151
R01 · FY2020 · HL
Scaffolds mimicking antigen presenting cells$600,000
R01 · FY2020 · FD · contact PI
3D Models of Immunotherapy$556,812
U01 · FY2020 · CA · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$550,464
R01 · FY2020 · DE · contact PI
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ$414,046
R01 · FY2020 · CA · contact PI
Biomaterials to Create T Cell Immunity$8,192,428
U54 · FY2019 · CA · contact PI
Michigan-Pittsburgh-Wyss Resource Center: Supporting Regenerative Medicine in Dental, Oral and Craniofacial Technologies$3,893,066
U24 · FY2019 · DE
Administrative Core$1,947,778
U54 · FY2019 · CA · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$813,563
R01 · FY2019 · DE · contact PI
Mechanisms of Prosthetic Arterial Bypass Graft Failure$756,151
R01 · FY2019 · HL
MSC Encapsulation with Thin Gel Coating$663,590
R01 · FY2019 · EB · contact PI
Scaffolds mimicking antigen presenting cells$600,000
R01 · FY2019 · FD · contact PI
3D Models of Immunotherapy$540,107
U01 · FY2019 · CA · contact PI
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ$400,995
R01 · FY2019 · CA · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$29,717
R01 · FY2019 · DE · contact PI
Michigan-Pittsburgh-Wyss Resource Center: Supporting Regenerative Medicine in Dental, Oral and Craniofacial Technologies$3,894,093
U24 · FY2018 · DE
Mechanisms of Prosthetic Arterial Bypass Graft Failure$749,995
R01 · FY2018 · HL
3D Models of Immunotherapy$729,562
U01 · FY2018 · CA · contact PI
MSC Encapsulation with Thin Gel Coating$665,836
R01 · FY2018 · EB · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$643,356
R01 · FY2018 · DE · contact PI
Scaffolds mimicking antigen presenting cells$600,000
R01 · FY2018 · FD · contact PI
Polymeric Matrices with Defined Cell Adhesion$518,763
R01 · FY2018 · DE · contact PI
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ$398,803
R01 · FY2018 · CA · contact PI
Michigan-Pittsburgh-Wyss Resource Center: Supporting Regenerative Medicine in Dental, Oral and Craniofacial Technologies$3,911,029
U24 · FY2017 · DE
Mechanisms of Prosthetic Arterial Bypass Graft Failure$768,102
R01 · FY2017 · HL
MSC Encapsulation with Thin Gel Coating$685,266
R01 · FY2017 · EB · contact PI
3D Models of Immunotherapy$574,412
U01 · FY2017 · CA · contact PI
Polymeric Matrices with Defined Cell Adhesion$502,750
R01 · FY2017 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$440,272
R01 · FY2016 · DE · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$394,909
R01 · FY2016 · DE · contact PI
Biomaterial based breast cancer vaccine$377,438
R01 · FY2016 · EB · contact PI
Role of Macrophages in Impaired Wound Healing in Type 1 Diabetes$2,432,818
DP3 · FY2015 · DK
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$752,707
R01 · FY2015 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$440,810
R01 · FY2015 · DE · contact PI
Biomaterial based breast cancer vaccine$369,889
R01 · FY2015 · EB · contact PI
Building the Hematopoietic Stem Cell Niche$779,887
R01 · FY2014 · EB · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$602,393
R01 · FY2014 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$447,810
R01 · FY2014 · DE · contact PI
Biomaterial based breast cancer vaccine$366,115
R01 · FY2014 · EB · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$304,010
R01 · FY2014 · DE · contact PI
Building the Hematopoietic Stem Cell Niche$768,726
R01 · FY2013 · EB · contact PI
Programming dendritic cells in concert with morphagen delivery for periodontal re$631,384
R01 · FY2013 · DE · contact PI
Engineering Capillary Networks$544,555
R01 · FY2013 · HL · contact PI
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$395,919
R01 · FY2013 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$391,350
R37 · FY2013 · DE · contact PI
Biomaterial based breast cancer vaccine$385,497
R01 · FY2013 · EB · contact PI
Building the Hematopoietic Stem Cell Niche$755,177
R01 · FY2012 · EB · contact PI
Programming dendritic cells in concert with morphagen delivery for periodontal re$681,377
R01 · FY2012 · DE · contact PI
Engineering Capillary Networks$611,759
R01 · FY2012 · HL · contact PI
Novel Therapeutic Approaches for the Management of Diebetic Foot Ulceration$524,379
R24 · FY2012 · DK
Engineering Skeletal Muscle WIth Biodegradable Hydrogels$428,932
R01 · FY2012 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$407,807
R37 · FY2012 · DE · contact PI
Building the Hematopoietic Stem Cell Niche$766,124
R01 · FY2011 · EB · contact PI
Programming dendritic cells in concert with morphagen delivery for periodontal re$704,509
R01 · FY2011 · DE · contact PI
Engineering Capillary Networks$571,354
R01 · FY2011 · HL · contact PI
Polymeric Matrices with Defined Cell Adhesion$359,381
R37 · FY2011 · DE · contact PI
Engineering Skeletal Muscle with Biodegradable Hydrogels$286,745
R01 · FY2011 · DE · contact PI
Programming dendritic cells in concert with morphagen delivery for periodontal re$749,117
R01 · FY2010 · DE · contact PI
Engineering Capillary Networks$601,797
R01 · FY2010 · HL · contact PI
Polymeric Matrices with Defined Cell Adhesion$370,496
R37 · FY2010 · DE · contact PI
Engineering Skeletal Muscle with Biodegradable Hydrogels$292,283
R01 · FY2010 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$54,400
R37 · FY2010 · DE · contact PI
Programming dendritic cells in concert with morphagen delivery for periodontal re$730,323
R01 · FY2009 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$369,403
R37 · FY2009 · DE · contact PI
Engineering Skeletal Muscle with Biodegradable Hydrogels$358,277
R01 · FY2009 · DE · contact PI
Engineering Skeletal Muscle with Biodegradable Hydrogels$300,544
R01 · FY2009 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$76,831
R37 · FY2009 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$346,030
R37 · FY2008 · DE · contact PI
Engineering Skeletal Muscle with Biodegradable Hydrogels$331,814
R01 · FY2008 · DE · contact PI
Engineering Skeletal Muscle with Biodegradable Hydrogels$353,228
R01 · FY2007 · DE · contact PI
Polymeric Matrices with Defined Cell Adhesion$349,879
R37 · FY2007 · DE · contact PI
Engineering capillary networks$476,802
R01 · FY2006 · HL · contact PI
Polymeric Matrices with Defined Cell Adhesion$360,329
R37 · FY2006 · DE · contact PI
Engineering capillary networks$481,520
R01 · FY2005 · HL
Polymeric Matrices with Defined Cell Adhesion$369,000
R37 · FY2005 · DE
Engineering capillary networks$489,422
R01 · FY2004 · HL
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$244,695
R01 · FY2004 · DE
Polymeric Matrices with Defined Cell Adhesion$229,500
R37 · FY2004 · DE
Polymeric Matrices with Defined Cell Adhesion$104,150
R37 · FY2004 · DE
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$79,715
R01 · FY2004 · DE
2004 Signal Transduction by Eng. Extracel. Matrices$22,000
R13 · FY2004 · EB
Tissue Engineering and Regeneration$3,456
T32 · FY2004 · DE
Tissue Engineering and Regeneration$585,009
T32 · FY2003 · DE
Engineering capillary networks$446,739
R01 · FY2003 · HL
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$248,117
R01 · FY2003 · DE
Tissue Engineering and Regeneration$93,024
T32 · FY2003 · DE
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$68,550
R01 · FY2003 · DE
Tissue Engineering and Regeneration$400,852
T32 · FY2002 · DE
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$240,890
R01 · FY2002 · DE
POLYMERIC MATRICES WITH DEFINED CELL ADHESION AND MECHAN$228,750
R01 · FY2002 · DE
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$32,719
R01 · FY2002 · DE
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$234,130
R01 · FY2001 · DE
POLYMERIC MATRICES WITH DEFINED CELL ADHESION AND MECHAN$228,750
R01 · FY2001 · DE
ENGINEERING SKELETAL MUSCLE WITH BIODEGRADABLE HYDROGELS$256,747
R01 · FY2000 · DE
POLYMERIC MATRICES WITH DEFINED CELL ADHESION AND MECHAN$228,750
R01 · FY2000 · DE
ENGINEERING FUNCTIONAL LIVER TISSUE$107,240
R29 · FY2000 · DK